MedCity News December 11, 2020
The future of precision medicine will come only as quickly as doctors can pick out clinically useful information from the genetic data being gathered on their patients.
The science is getting sharper and the barriers to reimbursement are eroding. But another major obstacle remains to delivering on the promise of precision medicine.
It involves getting the right information into the hands of front-line doctors in a way that they can use it, experts and entrepreneurs in the field said in a series of interviews with MedCity News.
“The critical information has to be on one page. The clinician has to be able to interpret it in one minute,” said Daniel Rhodes, co-founder and CEO of Strata Oncology, a genetic testing...
Today's Sponsors
Today's Sponsor